Bevacizumab Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
Non-small Cell Lung CancerAntineoplastic AgentsEGFR+5 more
Peng Zhang60 enrolled1 locationNCT06755684
Recruiting
Phase 1Phase 2
Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy
Neoadjuvant TreatmentRectal CancerRadiotherapy+1 more
Shanghai Minimally Invasive Surgery Center20 enrolled1 locationNCT05111860